계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Celator Pharmaceuticals
company
About
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
- 1 - 10
Highlights
Details
- Last Funding Type
- Debt Financing
- Last Funding Money Raised
- $15M
- Industries
- Biopharma,Biotechnology,Health Care,Health Diagnostics,Medical,Pharmaceutical
- Founded date
- Jan 1, 1999
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Celator Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat cancer. The company focuses on CombiPlex, a drug ratio technology platform that enables to the development of combination therapies. Its products include CPX-1 (Irinotecan HCI-Floxuridine), a treatment for colorectal cancer; and CPX-351 (Cytarabine-Daunorubicin), a treatment for acute myeloid leukemia (AML). Celator Pharmaceuticals, Inc. was formerly known as Celator Technologies, Inc. The company was founded in 2000 and is headquartered in Princeton, New Jersey.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$15M
Celator Pharmaceuticals has raised a total of
$15M
in funding over 2 rounds. Their latest funding was raised on
Jun 26, 2014 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 26, 2014 | Debt Financing | $15M | 1 |
Hercules Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Celator Pharmaceuticals is funded by 1 investors.
Hercules Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Hercules Capital
|
Yes | Debt Financing |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
